Effects of Hippotherapy in Children With Autism Spectrum Disorder
- Sponsor
- Fenerbahce University
- Study ID
- NCT07739693
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 7 Years - 15 Years
- Healthy Volunteers
- Not accepted
Interventions
- Hippotherapy Program — OTHERParticipants will receive 30-minute hippotherapy sessions once weekly for 8 weeks in addition to their ongoing special education program. The program will include exercises targeting balance, postural control, trunk stabilization, coordination, muscle strength, upper extremity function, and sensory processing.
- Special Education Program — OTHERParticipants will continue their ongoing special education program throughout the 8-week study period. The program includes educational activities, speech and language therapy, occupational therapy, proprioceptive activities, and sensory-based interventions according to the individual needs of the child.
Study Details
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by difficulties in social communication and interaction, as well as impairments in physical function domains such as postural control, balance, coordination, and motor planning. This study is designed as a randomized controlled trial to determine the effects of hippotherapy, applied in addition to a special education program, on physical function, bladder-bowel symptoms, and social communication level in children with ASD.
Key Dates
- First listed
- Jul 31, 2026
- Start date
- Aug 31, 2026
- Status verified
- Jul 2026
- Primary completion
- Mar 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Hippotherapy Group
- Active Comparator: Control Group
Primary Outcome Measure
Balance [ Time Frame: Baseline and at the end of the 8-week intervention ]
Central Contacts
- Seyda Toprak Celenay, PhD+90 312 906 2000
Find similar trials
Related Studies
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)PHASE2 · Recruiting · Montefiore Medical Center · The Bronx, New York
- Cerebellar Stimulation and Cognitive ControlRecruiting · Krystal Parker, PhD · Iowa City, Iowa
- SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of AutismRecruiting · American Federation of Medical Synergetics · Louisville, Kentucky
- Translating Evidence-based Interventions for ASD: Multi-Level Implementation StrategyEnrolling By Invitation · University of California, Davis · Sacramento, California